Nine months after two novel compounds or drug candidates for Ebola from the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) were shortlisted among 20 globally by the Public Health England (PHE), one of them has made it to the final three. And having realised the potential, PHE, which built and commissioned the first bio-safety level (BSL)4 facilities in the world (1976), designed the world’s first Class III safety cabinets, and used them to co-discover and characterise the Ebola virus, has signed a memorandum of understanding with JNCASR to co-develop the drug.
Bengaluru lab to co-develop Ebola drug
